NCT00465738 - IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity | Biotech Hunter

Enrollment

216

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

May 31, 2008

Conditions

Upper Limb Spasticity

Interventions

DRUG

"incobotulinumtoxinA (Xeomin, also known as NT 201 or Botulinum toxin type A (150 kD), free from complexing proteins)"

active ingredient: Clostridium Botulinum neurotoxin Type A free from complexing proteins; powder for solution for injection; Mode of administration: intramuscular injection; The content of the vial was dissolved in 2.0 or 5.0 mL of sterile sodium chloride \[NaCl\] 0.9% solution without preservatives. Dilution with 2.0 or 5.0 mL resulted in a dose of 50 or 20 units per 1.0 mL.

Trial Locations (27)

Unknown

Hermagor

Innsbruck

Vienna

Besançon

Garches

Lille

Paris

Beelitz-Heilstätten

Düsseldorf

Gladbeck

Bari

Costa Masnaga

Messina

Mestre

Milan

Rome

Lisbon

Tocha

Barcelona

Madrid

Terrassa

Bern

Nottwil

Kent

Liverpool

Plymouth

Wakefield